Shannon James Samuel made two open market purchases of Xilio Therapeutics Inc ($XLO) shares in the last year, totaling $48,085. His most recent buy occurred on June 17, 2025. These XLO insider buys rank 3,089th among 4,983 individuals in our database, well below the average purchase amount of $1.5 million across 3.3 transactions per buyer. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Xilio Therapeutics, Inc. | $XLO | Shannon James Samuel | Not found | P | Common Stock | 5000 | $8.79 | 10,000.0000 | 144,106,869 | 100.00% | 0.00% |
| March 1, 2026 | MANNKIND CORP | $MNKD | Shannon James Samuel | Not found | A | Common Stock, $0.01 Par Value | 12000 | $3.27 | 64,635.0000 | 313,339,000 | 22.80% | 0.00% |
| June 16, 2025 | Xilio Therapeutics, Inc. | $XLO | Shannon James Samuel | Not found | P | Common Stock | 45000 | $0.69 | 45,000.0000 | 63,465,063 | 9999.99% | 0.07% |
| June 17, 2025 | Xilio Therapeutics, Inc. | $XLO | Shannon James Samuel | Not found | P | Common Stock | 25000 | $0.69 | 70,000.0000 | 63,465,063 | 55.56% | 0.04% |
| June 11, 2025 | Xilio Therapeutics, Inc. | $XLO | Shannon James Samuel | Not found | A | Stock Option (right to buy) | 31000 | $0.00 | 31,000.0000 | 63,465,063 | 9999.99% | 0.05% |
| May 14, 2025 | MANNKIND CORP | $MNKD | Shannon James Samuel | Not found | A | Restricted Stock Unit | 52854 | $0.00 | 52,854.0000 | 283,844,000 | 9999.99% | 0.02% |
| June 13, 2024 | Xilio Therapeutics, Inc. | $XLO | Shannon James Samuel | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | MANNKIND CORP | $MNKD | Shannon James Samuel | Not found | A | Restricted Stock Unit | 35047 | $0.00 | 35,047.0000 | 267,014,000 | 9999.99% | 0.01% |